Childhood lupus nephritis : 12 years experience from North India

Twenty-five children (20 girls and five boys) with lupus nephritis seen over last 12 years, were evaluated. Twenty underwent renal biopsies. Cyclophosphamide pulse therapy was used in eight patients (median 14 pulses, range 6-16) with severe disease or histological class. Four of these eight patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rheumatology international 2006-05, Vol.26 (7), p.604-607
Hauptverfasser: SINGH, Surjit, DEVIDAYAL, MINZ, Ranjana, NADA, Ritambhra, JOSHI, Kusum
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 607
container_issue 7
container_start_page 604
container_title Rheumatology international
container_volume 26
creator SINGH, Surjit
DEVIDAYAL
MINZ, Ranjana
NADA, Ritambhra
JOSHI, Kusum
description Twenty-five children (20 girls and five boys) with lupus nephritis seen over last 12 years, were evaluated. Twenty underwent renal biopsies. Cyclophosphamide pulse therapy was used in eight patients (median 14 pulses, range 6-16) with severe disease or histological class. Four of these eight patients became asymptomatic (class IV, 2; class II and V, one each) after 4-24 months. Two (class III and IV, one each) died after a stable chronic renal insufficiency for almost a decade; one died 9 months after diagnosis (class IV). Of the 12 patients who underwent biopsy but were not treated with cyclophosphamide, six became asymptomatic during follow up (class II, four patients; class VI and V, one each), two continued to have proteinuria (class II), one (class IV) had raised ESR but normal renal functions and two died (class IV). Three of the five patients who were not biopsied remained asymptomatic; two were lost to follow up. Mortality was seen only with class III (one patient) or class IV (five patients) lesions. Outcome in lupus nephritis depends largely on WHO histological class. Cyclophosphamide pulse therapy is associated with a favorable outcome.
doi_str_mv 10.1007/s00296-005-0036-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_884133944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2428249561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-a5400d5f0ebf2559200508b302a2c443393c78c6d432062474416a090b0407a43</originalsourceid><addsrcrecordid>eNpNkEtLxDAUhYMozjj6A9xIEFxWbx5NWlfK4GNg0I2Cu5CmKc3QaWvSgvPvzTAFXdxcAt8553IQuiRwSwDkXQCguUgA0jhMJPkRmhPOZEIEfB2jORBJkyw-M3QWwgbiXwg4RTMiQbIom6OHZe2asu66EjdjPwbc2r72bnAB32NC8c5qH7D96a13tjUWV77b4rfODzVetaXT5-ik0k2wF9NeoM_np4_la7J-f1ktH9eJYakYEp1ygDKtwBYVTdOcxnTICgZUU8M5YzkzMjOi5IyCoFxyToSGHArgIDVnC3R98O199z3aMKhNN_o2Rqos4yQa8D1EDpDxXQjeVqr3bqv9ThFQ-8rUoTIV09W-MpVHzdVkPBZbW_4ppo4icDMBOhjdVF63xoV_nIw3E2C_Xy1wCQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>884133944</pqid></control><display><type>article</type><title>Childhood lupus nephritis : 12 years experience from North India</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>SINGH, Surjit ; DEVIDAYAL ; MINZ, Ranjana ; NADA, Ritambhra ; JOSHI, Kusum</creator><creatorcontrib>SINGH, Surjit ; DEVIDAYAL ; MINZ, Ranjana ; NADA, Ritambhra ; JOSHI, Kusum</creatorcontrib><description>Twenty-five children (20 girls and five boys) with lupus nephritis seen over last 12 years, were evaluated. Twenty underwent renal biopsies. Cyclophosphamide pulse therapy was used in eight patients (median 14 pulses, range 6-16) with severe disease or histological class. Four of these eight patients became asymptomatic (class IV, 2; class II and V, one each) after 4-24 months. Two (class III and IV, one each) died after a stable chronic renal insufficiency for almost a decade; one died 9 months after diagnosis (class IV). Of the 12 patients who underwent biopsy but were not treated with cyclophosphamide, six became asymptomatic during follow up (class II, four patients; class VI and V, one each), two continued to have proteinuria (class II), one (class IV) had raised ESR but normal renal functions and two died (class IV). Three of the five patients who were not biopsied remained asymptomatic; two were lost to follow up. Mortality was seen only with class III (one patient) or class IV (five patients) lesions. Outcome in lupus nephritis depends largely on WHO histological class. Cyclophosphamide pulse therapy is associated with a favorable outcome.</description><identifier>ISSN: 0172-8172</identifier><identifier>EISSN: 1437-160X</identifier><identifier>DOI: 10.1007/s00296-005-0036-9</identifier><identifier>PMID: 17073005</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Biological and medical sciences ; Child ; Child, Preschool ; Cyclophosphamide - administration &amp; dosage ; Cyclophosphamide - adverse effects ; Diseases of the osteoarticular system ; Female ; Follow-Up Studies ; Humans ; Kidney diseases ; Kidneys ; Lupus ; Lupus Nephritis - blood ; Lupus Nephritis - mortality ; Lupus Nephritis - therapy ; Male ; Medical sciences ; Mortality ; Nephrology. Urinary tract diseases ; Prognosis ; Urinary system involvement in other diseases. Miscellaneous</subject><ispartof>Rheumatology international, 2006-05, Vol.26 (7), p.604-607</ispartof><rights>2006 INIST-CNRS</rights><rights>Springer-Verlag 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-a5400d5f0ebf2559200508b302a2c443393c78c6d432062474416a090b0407a43</citedby><cites>FETCH-LOGICAL-c356t-a5400d5f0ebf2559200508b302a2c443393c78c6d432062474416a090b0407a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17743210$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17073005$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SINGH, Surjit</creatorcontrib><creatorcontrib>DEVIDAYAL</creatorcontrib><creatorcontrib>MINZ, Ranjana</creatorcontrib><creatorcontrib>NADA, Ritambhra</creatorcontrib><creatorcontrib>JOSHI, Kusum</creatorcontrib><title>Childhood lupus nephritis : 12 years experience from North India</title><title>Rheumatology international</title><addtitle>Rheumatol Int</addtitle><description>Twenty-five children (20 girls and five boys) with lupus nephritis seen over last 12 years, were evaluated. Twenty underwent renal biopsies. Cyclophosphamide pulse therapy was used in eight patients (median 14 pulses, range 6-16) with severe disease or histological class. Four of these eight patients became asymptomatic (class IV, 2; class II and V, one each) after 4-24 months. Two (class III and IV, one each) died after a stable chronic renal insufficiency for almost a decade; one died 9 months after diagnosis (class IV). Of the 12 patients who underwent biopsy but were not treated with cyclophosphamide, six became asymptomatic during follow up (class II, four patients; class VI and V, one each), two continued to have proteinuria (class II), one (class IV) had raised ESR but normal renal functions and two died (class IV). Three of the five patients who were not biopsied remained asymptomatic; two were lost to follow up. Mortality was seen only with class III (one patient) or class IV (five patients) lesions. Outcome in lupus nephritis depends largely on WHO histological class. Cyclophosphamide pulse therapy is associated with a favorable outcome.</description><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cyclophosphamide - administration &amp; dosage</subject><subject>Cyclophosphamide - adverse effects</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Kidney diseases</subject><subject>Kidneys</subject><subject>Lupus</subject><subject>Lupus Nephritis - blood</subject><subject>Lupus Nephritis - mortality</subject><subject>Lupus Nephritis - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mortality</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Prognosis</subject><subject>Urinary system involvement in other diseases. Miscellaneous</subject><issn>0172-8172</issn><issn>1437-160X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpNkEtLxDAUhYMozjj6A9xIEFxWbx5NWlfK4GNg0I2Cu5CmKc3QaWvSgvPvzTAFXdxcAt8553IQuiRwSwDkXQCguUgA0jhMJPkRmhPOZEIEfB2jORBJkyw-M3QWwgbiXwg4RTMiQbIom6OHZe2asu66EjdjPwbc2r72bnAB32NC8c5qH7D96a13tjUWV77b4rfODzVetaXT5-ik0k2wF9NeoM_np4_la7J-f1ktH9eJYakYEp1ygDKtwBYVTdOcxnTICgZUU8M5YzkzMjOi5IyCoFxyToSGHArgIDVnC3R98O199z3aMKhNN_o2Rqos4yQa8D1EDpDxXQjeVqr3bqv9ThFQ-8rUoTIV09W-MpVHzdVkPBZbW_4ppo4icDMBOhjdVF63xoV_nIw3E2C_Xy1wCQ</recordid><startdate>20060501</startdate><enddate>20060501</enddate><creator>SINGH, Surjit</creator><creator>DEVIDAYAL</creator><creator>MINZ, Ranjana</creator><creator>NADA, Ritambhra</creator><creator>JOSHI, Kusum</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20060501</creationdate><title>Childhood lupus nephritis : 12 years experience from North India</title><author>SINGH, Surjit ; DEVIDAYAL ; MINZ, Ranjana ; NADA, Ritambhra ; JOSHI, Kusum</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-a5400d5f0ebf2559200508b302a2c443393c78c6d432062474416a090b0407a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cyclophosphamide - administration &amp; dosage</topic><topic>Cyclophosphamide - adverse effects</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Kidney diseases</topic><topic>Kidneys</topic><topic>Lupus</topic><topic>Lupus Nephritis - blood</topic><topic>Lupus Nephritis - mortality</topic><topic>Lupus Nephritis - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mortality</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Prognosis</topic><topic>Urinary system involvement in other diseases. Miscellaneous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SINGH, Surjit</creatorcontrib><creatorcontrib>DEVIDAYAL</creatorcontrib><creatorcontrib>MINZ, Ranjana</creatorcontrib><creatorcontrib>NADA, Ritambhra</creatorcontrib><creatorcontrib>JOSHI, Kusum</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Rheumatology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SINGH, Surjit</au><au>DEVIDAYAL</au><au>MINZ, Ranjana</au><au>NADA, Ritambhra</au><au>JOSHI, Kusum</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Childhood lupus nephritis : 12 years experience from North India</atitle><jtitle>Rheumatology international</jtitle><addtitle>Rheumatol Int</addtitle><date>2006-05-01</date><risdate>2006</risdate><volume>26</volume><issue>7</issue><spage>604</spage><epage>607</epage><pages>604-607</pages><issn>0172-8172</issn><eissn>1437-160X</eissn><abstract>Twenty-five children (20 girls and five boys) with lupus nephritis seen over last 12 years, were evaluated. Twenty underwent renal biopsies. Cyclophosphamide pulse therapy was used in eight patients (median 14 pulses, range 6-16) with severe disease or histological class. Four of these eight patients became asymptomatic (class IV, 2; class II and V, one each) after 4-24 months. Two (class III and IV, one each) died after a stable chronic renal insufficiency for almost a decade; one died 9 months after diagnosis (class IV). Of the 12 patients who underwent biopsy but were not treated with cyclophosphamide, six became asymptomatic during follow up (class II, four patients; class VI and V, one each), two continued to have proteinuria (class II), one (class IV) had raised ESR but normal renal functions and two died (class IV). Three of the five patients who were not biopsied remained asymptomatic; two were lost to follow up. Mortality was seen only with class III (one patient) or class IV (five patients) lesions. Outcome in lupus nephritis depends largely on WHO histological class. Cyclophosphamide pulse therapy is associated with a favorable outcome.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>17073005</pmid><doi>10.1007/s00296-005-0036-9</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0172-8172
ispartof Rheumatology international, 2006-05, Vol.26 (7), p.604-607
issn 0172-8172
1437-160X
language eng
recordid cdi_proquest_journals_884133944
source MEDLINE; SpringerNature Journals
subjects Biological and medical sciences
Child
Child, Preschool
Cyclophosphamide - administration & dosage
Cyclophosphamide - adverse effects
Diseases of the osteoarticular system
Female
Follow-Up Studies
Humans
Kidney diseases
Kidneys
Lupus
Lupus Nephritis - blood
Lupus Nephritis - mortality
Lupus Nephritis - therapy
Male
Medical sciences
Mortality
Nephrology. Urinary tract diseases
Prognosis
Urinary system involvement in other diseases. Miscellaneous
title Childhood lupus nephritis : 12 years experience from North India
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T16%3A56%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Childhood%20lupus%20nephritis%20:%2012%20years%20experience%20from%20North%20India&rft.jtitle=Rheumatology%20international&rft.au=SINGH,%20Surjit&rft.date=2006-05-01&rft.volume=26&rft.issue=7&rft.spage=604&rft.epage=607&rft.pages=604-607&rft.issn=0172-8172&rft.eissn=1437-160X&rft_id=info:doi/10.1007/s00296-005-0036-9&rft_dat=%3Cproquest_cross%3E2428249561%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=884133944&rft_id=info:pmid/17073005&rfr_iscdi=true